{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:41:57Z","timestamp":1777866117894,"version":"3.51.4"},"reference-count":37,"publisher":"China Science Publishing & Media Ltd.","issue":"4","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.3724\/abbs.2025110","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:10:39Z","timestamp":1751494239000},"page":"819-832","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Directly targeting G-quadruplexes contributes to the                     anti-multiple myeloma efficacy of Epimedokoreanin B"],"prefix":"10.3724","volume":"58","author":[{"given":"Pingting","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangzhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"Cowan AJ","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, Tuazon S. Diagnosis and management of multiple myeloma. JAMA, 2022, 327:","journal-title":"JAMA"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1182\/blood.2022017635","volume":"143","author":"Facon T","year":"2024","unstructured":"Facon T, Leleu X, Manier S. How I treat multiple myeloma in geriatric patients. Blood, 2024, 143: 224-232.","journal-title":"Blood"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/oncolo\/oyad306","volume":"29","author":"Rafae A","year":"2024","unstructured":"Rafae A, van Rhee F, Al Hadidi S. Perspectives on the treatment of multiple myeloma. Oncologist, 2024, 29: 200-212.","journal-title":"Oncologist"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00277-024-05730-y","volume":"103","author":"Chen Q","year":"2024","unstructured":"Chen Q, Zhang M, Zheng S, Tong Y, Tan Y. Therapeutic progress in relapsed\/refractory multiple myeloma. Ann Hematol, 2024, 103: 1833-1841.","journal-title":"Ann Hematol"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"11593","DOI":"10.1073\/pnas.182256799","volume":"99","author":"Siddiqui-Jain A","year":"2002","unstructured":"Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH. Direct evidence for a G-quadruplex in a promoter region and its                         targeting with a small molecule to repress c-MYC                         transcription. Proc Natl Acad Sci                             USA, 2002, 99: 11593-11598.","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"103756","DOI":"10.1016\/j.ebiom.2021.103756","volume":"75","author":"Llombart V","year":"2022","unstructured":"Llombart V, Mansour MR. Therapeutic targeting of \u201cundruggable\u201d MYC. eBioMedicine, 2022, 75:","journal-title":"eBioMedicine"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1038\/s41388-020-1345-x","volume":"39","author":"Crawford LJ","year":"2020","unstructured":"Crawford LJ, Campbell DC, Morgan JJ, Lawson MA, Down JM, Chauhan D, McAvera RM. The E3 ligase HUWE1 inhibition as a therapeutic strategy to                         target MYC in multiple myeloma. Oncogene, 2020, 39: 5001-5014.","journal-title":"Oncogene"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1021\/acs.jmedchem.0c01145","volume":"64","author":"Chaudhuri R","year":"2021","unstructured":"Chaudhuri R, Bhattacharya S, Dash J, Bhattacharya S. Recent update on targeting c-MYC G-quadruplexes                         by small molecules for anticancer therapeutics. J Med Chem, 2021, 64: 42-70.","journal-title":"J Med Chem"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/biomedicines11030969","volume":"11","author":"Bahls B","year":"2023","unstructured":"Bahls B, Aljnadi IM, Em\u00eddio R, Mendes E, Paulo A. G-quadruplexes in c-MYC promoter as targets for cancer therapy. Biomedicines, 2023, 11:","journal-title":"Biomedicines"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.1021\/ja050823u","volume":"127","author":"Rankin S","year":"2005","unstructured":"Rankin S, Reszka AP, Huppert J, Zloh M, Parkinson GN, Todd AK, Ladame S. Putative DNA quadruplex formation within the human c-kit                         oncogene. J Am Chem Soc, 2005, 127: 10584-10589.","journal-title":"J Am Chem Soc"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1021\/ja055636a","volume":"128","author":"Dai J","year":"2006","unstructured":"Dai J, Dexheimer TS, Chen D, Carver M, Ambrus A, Jones RA, Yang D. An intramolecular G-quadruplex structure with mixed                         parallel\/antiparallel G-strands formed in the human BCL-2 promoter region in                         solution. J Am Chem Soc, 2006, 128: 1096-1098.","journal-title":"J Am Chem Soc"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1093\/nar\/gkn120","volume":"36","author":"Cogoi S","year":"2008","unstructured":"Cogoi S, Paramasivam M, Spolaore B, Xodo LE. Structural polymorphism within a regulatory element of the human                         KRAS promoter: formation of G4-DNA recognized by nuclear proteins. Nucleic Acids Res, 2008, 36: 3765-3780.","journal-title":"Nucleic Acids Res"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","volume":"91","author":"Bamford S","year":"2004","unstructured":"Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, Flanagan A. The COSMIC (catalogue of somatic mutations in cancer) database                         and website. Br J Cancer, 2004, 91: 355-358.","journal-title":"Br J Cancer"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"e2013230118","DOI":"10.1073\/pnas.2013230118","volume":"118","author":"Gong J","year":"2021","unstructured":"Gong J, Wen C, Tang M, Duan R, Chen J, Zhang J, Zheng K. G-quadruplex structural variations in human genome associated                         with single-nucleotide variations and their impact on gene activity. Proc Natl Acad Sci                             USA, 2021, 118:","journal-title":"Proc Natl Acad Sci                             USA"},{"key":"CITATION15","doi-asserted-by":"crossref","unstructured":"Neidle S. Quadruplex nucleic acids as targets for anticancer                         therapeutics.                              Nat                         Rev Chem                          2017, 1: 0041.","DOI":"10.1038\/s41570-017-0041"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"6557","DOI":"10.1007\/s00018-021-03921-8","volume":"78","author":"Teng FY","year":"2021","unstructured":"Teng FY, Jiang ZZ, Guo M, Tan XZ, Chen F, Xi XG, Xu Y. G-quadruplex DNA: a novel target for drug design. Cell Mol Life                             Sci, 2021, 78: 6557-6583.","journal-title":"Cell Mol Life                             Sci"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrc2733","volume":"9","author":"Brooks TA","year":"2009","unstructured":"Brooks TA, Hurley LH. The role of supercoiling in transcriptional control of MYC and                         its importance in molecular therapeutics. Nat Rev Cancer, 2009, 9: 849-861.","journal-title":"Nat Rev Cancer"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.eng.2024.03.015","volume":"38","author":"Wang KB","year":"2024","unstructured":"Wang KB, Wang Y, Dickerhoff J, Yang D. DNA G-quadruplexes as targets for natural product drug discovery. Engineering, 2024, 38: 39-51.","journal-title":"Engineering"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"110125","DOI":"10.1016\/j.cbi.2022.110125","volume":"366","author":"Zheng H","year":"2022","unstructured":"Zheng H, Liu Q, Wang S, Liu X, Ma M, Shen T, Wang X. Epimedokoreanin B inhibits the growth of lung cancer cells                         through endoplasmic reticulum stress-mediated paraptosis accompanied by                         autophagosome accumulation. Chem-Biol                             Interact, 2022, 366:","journal-title":"Chem-Biol                             Interact"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1080\/09168451.2019.1597615","volume":"83","author":"Kariu T","year":"2019","unstructured":"Kariu T, Ikeda T, Nakashima K, Potempa J, Imamura T. A natural anti-periodontitis agent, epimedokoreanin B, inhibits                         virulence activities of gingipains from Porphyromonas gingivalis. Biosci                             Biotechnol Biochem, 2019, 83: 1382-1384.","journal-title":"Biosci                             Biotechnol Biochem"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2020.00262","volume":"11","author":"Pan C","year":"2020","unstructured":"Pan C, Fujiwara Y, Horlad H, Shiraishi D, Iriki T, Tsuboki J, Ikeda T. Flavonoid compounds contained in epimedii herba inhibit tumor                         progression by suppressing STAT3 activation in the tumor microenvironment. Front Pharmacol, 2020, 11:","journal-title":"Front Pharmacol"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","volume":"281","author":"He TC","year":"1998","unstructured":"He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ. Identification of c-MYC as a target of the APC pathway. Science, 1998, 281: 1509-1512.","journal-title":"Science"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"17673","DOI":"10.1021\/ja205646q","volume":"133","author":"Dai J","year":"2011","unstructured":"Dai J, Carver M, Hurley LH, Yang D. Solution structure of a 2:1 quindoline-c-MYC G-quadruplex:                         insights into G-quadruplex-interactive small molecule drug design. J Am Chem Soc, 2011, 133: 17673-17680.","journal-title":"J Am Chem Soc"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1093\/nar\/gks023","volume":"40","author":"Wei D","year":"2012","unstructured":"Wei D, Parkinson GN, Reszka AP, Neidle S. Crystal structure of a c-kit promoter quadruplex reveals the                         structural role of metal ions and water molecules in maintaining loop                         conformation. Nucleic Acids Res, 2012, 40: 4691-4700.","journal-title":"Nucleic Acids Res"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1093\/nar\/gkl610","volume":"34","author":"Dai J","year":"2006","unstructured":"Dai J, Chen D, Jones RA, Hurley LH, Yang D. NMR solution structure of the major G-quadruplex structure formed                         in the human BCL2 promoter region. Nucleic Acids Res, 2006, 34: 5133-5144.","journal-title":"Nucleic Acids Res"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"8082","DOI":"10.1074\/jbc.M117.781906","volume":"292","author":"Kerkour A","year":"2017","unstructured":"Kerkour A, Marquevielle J, Ivashchenko S, Yatsunyk LA, Mergny JL, Salgado GF. High-resolution three-dimensional NMR structure of the KRAS                         proto-oncogene promoter reveals key features of a G-quadruplex involved in                         transcriptional regulation. J Biol Chem, 2017, 292: 8082-8091.","journal-title":"J Biol Chem"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"14432","DOI":"10.1038\/ncomms14432","volume":"8","author":"Xu H","year":"2017","unstructured":"Xu H, Di Antonio M, McKinney S, Mathew V, Ho B, O\u2019Neil NJ, Santos ND. CX-5461 is a DNA G-quadruplex stabilizer with selective lethality                         in BRCA1\/2 deficient tumours. Nat Commun, 2017, 8:","journal-title":"Nat Commun"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"e102711","DOI":"10.1371\/journal.pone.0102711","volume":"9","author":"Biffi G","year":"2014","unstructured":"Biffi G, Tannahill D, Miller J, Howat WJ, Balasubramanian S, Isalan M. Elevated levels of G-quadruplex formation in human stomach and                         liver cancer tissues. PLoS One, 2014, 9:","journal-title":"PLoS One"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"134673","DOI":"10.1016\/j.molstruc.2022.134673","volume":"1275","author":"Geng X","year":"2023","unstructured":"Geng X, Zhang Y, Li S, Liu L, Yao R, Liu L, Gao J. Design, synthesis, and biological evaluation of novel                         benzimidazolyl isoxazole derivatives as potential c-Myc G4 stabilizers to                         suppress c-Myc transcription and myeloma growth. J Mol                             Structure, 2023, 1275:","journal-title":"J Mol                             Structure"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"107173","DOI":"10.1016\/j.bioorg.2024.107173","volume":"144","author":"Cai JH","year":"2024","unstructured":"Cai JH, Yang DY, Zhang JJ, Tan JH, Huang ZS, Chen SB. Constructing triazole-modified quinazoline derivatives as                         selective c-MYC G-quadruplex ligands and potent anticancer agents through                         click chemistry. Bioorg Chem, 2024, 144:","journal-title":"Bioorg Chem"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"107842","DOI":"10.1016\/j.bioorg.2024.107842","volume":"153","author":"Zhong LT","year":"2024","unstructured":"Zhong LT, Yuan JM, Fu WL, Zhang ZL, Li X, Ou TM, Tan JH. Identification of sanguinarine as c-MYC transcription inhibitor                         through enhancing the G-quadruplex-NM23-H2 interactions. Bioorg Chem, 2024, 153:","journal-title":"Bioorg Chem"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1007\/s11030-023-10789-2","volume":"28","author":"Gao J","year":"2024","unstructured":"Gao J, Liang C, Yin J, Bai Y, Hu D. Discovery of Palbociclib as a potent c-Myc G4 stabilizer for lung                         cancer treatment using molecular docking, molecular dynamics simulation, and in                         vitro activity evaluation. Mol Divers, 2024, 28: 3965-3977.","journal-title":"Mol Divers"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1080\/17460441.2024.2404230","volume":"19","author":"Sanchez-Martin V","year":"2024","unstructured":"Sanchez-Martin V. Opportunities and challenges with G-quadruplexes as promising                         targets for drug design. Expert Opin                             Drug Discov, 2024, 19: 1339-1353.","journal-title":"Expert Opin                             Drug Discov"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.3390\/ijms22115947","volume":"22","author":"Alessandrini I","year":"2021","unstructured":"Alessandrini I, Recagni M, Zaffaroni N, Folini M. On the road to fight cancer: the potential of G-quadruplex                         ligands as novel therapeutic agents. Int J Mol Sci, 2021, 22:","journal-title":"Int J Mol Sci"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1021\/acs.accounts.2c00337","volume":"55","author":"Chen L","year":"2022","unstructured":"Chen L, Dickerhoff J, Sakai S, Yang D. DNA G-quadruplex in human telomeres and oncogene promoters:                         structures, functions, and small molecule targeting. Acc Chem Res, 2022, 55: 2628-2646.","journal-title":"Acc Chem Res"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12967-025-06473-8","volume":"23","author":"Li HX","year":"2025","unstructured":"Li HX, He YM, Fei J, Guo M, Zeng C, Yan PJ, Xu Y. The G-quadruplex ligand CX-5461: an innovative candidate for                         disease treatment. J Transl Med, 2025, 23:","journal-title":"J Transl Med"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"7653","DOI":"10.1158\/0008-5472.CAN-09-1304","volume":"69","author":"Drygin D","year":"2009","unstructured":"Drygin D, Siddiqui-Jain A, O\u2032Brien S, Schwaebe M, Lin A, Bliesath J, Ho CB. Anticancer activity of CX-3543: a direct inhibitor of rRNA                         biogenesis. Cancer Res, 2009, 69: 7653-7661.","journal-title":"Cancer Res"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/2EB9030E674B4F7AAB50290670BA319E","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025110","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/2EB9030E674B4F7AAB50290670BA319E","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:03:04Z","timestamp":1777536184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,14]]},"published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2025110","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,14]]}}}